Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85ff6e725385ab8f9cce00156335569d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-203 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-108 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
filingDate |
2009-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dbfa9088cd3ecaefb0655185613d27f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6af8f19bd3d379563a2aaaf30066b6bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e231ebe49048a4b395a1de2f51bd8957 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5609976a72974dfee69ef7aba1a3826e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ff82a7abeb55a8388784656b0eb8fc9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c8eb6eb3c7cc4129618ca12a3735705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a4b87bf629b47772bb2749f3b01ff1c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ba14fa784db30c72ae4806e4de429c1 |
publicationDate |
2009-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2009252707-A1 |
titleOfInvention |
Novel expression vectors and uses thereof |
abstract |
A method for treating an HIV disease in a subject in need of said treatment, comprising administering to the subject a therapeutically effective amount of a DNA vaccine comprising an expression vector and a pharmaceutically acceptable excipient, where the expression vector comprises: (a) a heterologous promoter operatively linked to a DNA sequence encoding a nuclear-anchoring protein, where the nuclear-anchoring protein comprises: (i) a DNA binding domain which binds to a specific DNA binding sequence, and (ii) a functional domain of the Bovine Papilloma Virus Type 1 E2 protein, where the functional domain binds to a nuclear component; (b) a multimerized DNA sequence that forms a binding site for the nuclear anchoring protein; and (c) at least one expression cassette comprising a DNA sequence encoding a protein or peptide that stimulates an immune response specific to the protein or peptide; where the expression vector lacks an origin of replication functional in mammalian cells. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10190113-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8940296-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8927218-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9790486-B2 |
priorityDate |
2001-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |